Dense net stent and preparation method thereof
By braiding and heat-treated on the mandrel, the long-standing problems of the stent after FD treatment are solved, the degradation and absorption of the stent and vascular recovery are achieved, and the treatment effect and safety are improved.
Patent Information
- Application Number
- CN202310629511.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
The existing novel blood flow guide device (FD) has long-term existence after the treatment of large or giant intracranial aneurysms, resulting in intrastent stenosis, inflammatory response, hindering normal vascular growth and thrombosis, and cannot be removed, affecting the treatment effect and the patient. healthy.
Design a degradable dense mesh bracket, which forms a hollow tubular bracket by braiding multiple degradable wires on the mandrel and performing heat treatment to fix the intersection points, ensuring the mechanical properties and degradability of the bracket, achieving the blood flow guidance function while achieving the simultaneous Eliminate the placeholding effect.
The stent can be degraded and absorbed after tumor occlusion, restores vascular status, reduces long-term safety hazards, improves treatment effect, reduces treatment costs, and reduces thrombosis risk.
Smart Images

Figure CN119061577A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a dense mesh stent and a preparation method thereof. Background Art
[0002] With the improvement of domestic living standards and the advancement of medical diagnostic technology, the incidence of vascular diseases caused by abnormal changes or aging of blood vessels is also increasing year by year. The manifestations include intracranial aneurysms, visceral aneurysms and peripheral aneurysms, arteriovenous malformations and hemangiomas. For such diseases, the treatment options adopted at home and abroad mainly include surgical treatment and interventional treatment. Due to the huge trauma and a series of complications caused by surgical treatment, endovascular interventional minimally invasive treatment options are increasingly favored by doctors and patients. A blood flow guide device, also known as a dense mesh stent, is implanted in the parent artery of a large or giant aneurysm to change the hemodynamics and achieve complete embolism or thrombosis to achieve the purpose of treatment.
[0003] Large intracranial aneurysms or giant aneurysms are often large in size, located deep in the skull, often involving some important vascular branches, with wide necks and various tumor shapes. They are often accompanied by secondary changes such as intracavitary thrombosis, wall calcification, and atherosclerotic plaques. They are difficult to treat by direct craniotomy and clipping. Traditional interventional treatment techniques such as simple dense mesh stent embolization, stent-assisted embolization, balloon-assisted embolization, and parent artery occlusion have high recurrence and complication rates. In recent years, new blood flow diverters (FDs) have gradually begun to be used in the treatment of intracranial aneurysms in clinical practice.
[0004] The current literature reports on the new blood flow diversion device for the treatment of unruptured large or giant intracranial aneurysms have confirmed the safety and effectiveness of FD in treating this type of aneurysm. The mechanism of FD treatment is different from that of traditional endovascular treatment. The direction of traditional endovascular treatment is mainly aimed at the aneurysm cavity itself, while the direction of FD treatment is to repair the parent artery. FD treatment is a type of stent developed based on the research on intracranial aneurysms and the hemodynamics of parent arteries. Due to its high metal coverage and high mesh density design, FD treatment can reshape the blood flow in the neck of the parent aneurysm, direct the blood flow that impacts the aneurysm to the normal blood vessels at the distal end of the parent artery, reduce the impact of blood flow on the aneurysm, and restore the hemodynamics of the neck of the parent aneurysm, thereby promoting thrombosis in the aneurysm cavity, gradually shrinking the aneurysm cavity, and eventually healing. After FD implantation, it can provide a "scaffold" for vascular endothelial cells to climb and grow, promote the endothelialization of the aneurysm neck, and after the vascular endothelial cells cover the stent, the parent artery and the aneurysm cavity are isolated, which can significantly reduce the risk of aneurysm rupture and recurrence. After the aneurysm neck is endothelialized, a permanent biological closure will be formed at its location. During the endothelialization of the aneurysm neck, the aneurysm cavity will gradually shrink, and finally achieve complete anatomical cure. However, despite the development and success of FD treatment, they are still associated with clinically significant long-term complications, such as delayed thrombosis, in-stent stenosis, and induction of inflammatory response leading to intimal hyperplasia. Usually in 6-12 months, the aneurysm is completely occluded, vascular remodeling and neointima have been fully formed, and at this time the FD may no longer be needed, but it cannot be removed. The long-term presence of FD may lead to late stent thrombosis, late restenosis, inflammatory response of the host tissue, obstruction of normal arterial growth and vascular movement, restriction of future surgical repair of collaterals, interference with adjacent tissue structures, and imaging display of pathology. In addition, after stent implantation, patients are required to take antiplatelet drugs for life, which leads to increased treatment-related costs, the risk of long-term bleeding and other drug side effects. Moreover, the long-term presence of FD will also affect postoperative CT / MR examinations.
[0005] Therefore, it has become a necessary requirement to develop a FD that can gradually degrade and disappear after the tumor is completely occluded. However, most of the existing degradable stents are not suitable for use on FD, such as the stent is too thick, the inner cavity of the stent is not round, and the overall mechanical properties of the stent are uneven. Therefore, for those skilled in the art, how to design an absorbable dense mesh stent that can be applied to FD is a technical problem that needs to be solved urgently.
[0006] It should be noted that the information disclosed in the background technology section of this application is only intended to deepen the understanding of the general background technology of this application, and should not be regarded as an admission or suggestion in any form that the information constitutes prior art already known to those skilled in the art. Summary of the invention
[0007] The purpose of the present invention is to provide a dense mesh stent and a preparation method thereof, aiming to provide a degradable stent suitable for the treatment of FD, which can eliminate or alleviate the space-occupying effect while realizing the blood flow guidance function of the metal stent, and also eliminate the long-term safety hazards of the stent in the body for a long time.
[0008] To achieve the above object, the present invention provides a method for preparing a dense mesh stent, comprising:
[0009] providing a plurality of filaments, at least some of which are degradable filaments;
[0010] Weaving a plurality of the filaments on a core shaft to form a hollow tubular stent;
[0011] After forming the hollow tubular stent, heating the mandrel to perform heat treatment on the hollow tubular stent on the mandrel;
[0012] After the heat treatment, the hollow tubular support is cooled, and then the hollow tubular support and the mandrel are separated to obtain a dense mesh support provided by the hollow tubular support;
[0013] Wherein, a plurality of the wires are crossed with each other to form a plurality of intersections and a plurality of meshes, and at least part of the wires are fixed at the corresponding intersections.
[0014] Optionally, the heating temperature of the mandrel is a first temperature, which is higher than the glass transition temperature of the filament and does not exceed the initial melting point of the filament.
[0015] Optionally, the absolute value of the difference between the first temperature and the initial melting point of the silk is 0-20°C.
[0016] Optionally, the first temperature is configured to satisfy at least one of the following conditions:
[0017] Condition 1: melting the filaments into one at the corresponding intersections;
[0018] Condition 2: slightly melting the part of the material of the hollow tubular stent close to the core shaft so that the wall thickness of the hollow tubular stent does not exceed the wire diameter of the round wire;
[0019] Condition three: slightly melt the part of the material of the hollow tubular support close to the core shaft to make the inner wall of the hollow tubular support smooth.
[0020] Optionally, when the first temperature is configured to satisfy the second condition, the wall thickness of the hollow tubular support is 0.5 to 1.0 times the diameter of the circular wire.
[0021] Optionally, after separating the hollow tubular stent and the mandrel, the method further comprises:
[0022] A liquid containing medical glue is applied to the intersections where the wires are fixed.
[0023] Optionally, the liquid further comprises a developer.
[0024] Optionally, the heating temperature of the mandrel is a second temperature, the second temperature is higher than the glass transition temperature of the filament, and the absolute value of the difference between the second temperature and the glass transition temperature is 0 to 50°C.
[0025] Optionally, the wire diameter is 0.0010in to 0.0045in.
[0026] Optionally, the wall thickness of the hollow tubular support does not exceed 100 μm.
[0027] Optionally, the braiding angle of the hollow tubular stent is 9° to 45°, and the blank rate of the hollow tubular stent is 60% to 90%.
[0028] Optionally, the method further includes: enabling the hollow tubular stent to be fully developed through at least one development method.
[0029] Optionally, the hollow tubular stent can be fully developed by at least one of the following development methods, including:
[0030] Development method 1: coating a developer on at least part of the intersections;
[0031] Development method 2: all the silks are degradable silks, and a developer is coated on the surface of at least part of the degradable silks;
[0032] Development method three: some of the wires are developable metal wires;
[0033] Development method 4: spraying or dipping the developer on the hollow tubular support;
[0034] Development method five: winding a developable metal wire around at least a portion of the wire.
[0035] Optionally, all of the wires are fixed at corresponding intersections.
[0036] Optionally, the method further includes: during the weaving process, detecting the thread tension in real time, and adjusting the thread tension if the detected thread tension does not meet the requirements.
[0037] Based on the same inventive concept, the present invention also provides a dense mesh stent, which is prepared by any of the preparation methods of the dense mesh stent.
[0038] Compared with the prior art, the dense mesh stent and the preparation method thereof of the present invention have the following advantages:
[0039] The dense mesh stent prepared by the above preparation method has at least part of the silk being degradable, so that the dense mesh stent can be degraded and absorbed after being implanted and curing the tumor, and while achieving the basic function of metal blood flow guidance to eliminate or alleviate the intracranial space-occupying effect, the blood vessels are restored to their original state through the degradation and absorption of the degradable material, eliminating the long-term safety hazards of the stent, ultimately improving the treatment effect and reducing the treatment cost. At the same time, at least part of the silk is fixed at the intersection, so that the radial support force of the dense mesh stent can be improved, so that the radial support force and local compressive resistance of the dense mesh stent can reach the level of metal stents, ensuring that the stent has a stable blood flow guidance function in the early stage of implantation.
[0040] Moreover, when multiple wires are directly woven on the core shaft to form a hollow tubular stent, each wire can be uniformly shrunk toward the core shaft and fit tightly to the core shaft, thus ensuring the stability of the overall shape of the stent and the uniformity of the mechanical properties, and better controlling the wall thickness of the stent, reducing the risk of thrombosis, and at the same time better controlling the inner diameter of the stent, making the inner cavity of the dense mesh stent almost a standard circle, giving the dense mesh stent better roundness, and reducing the probability of thrombosis in the stent caused by possible vortexes in the blood. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Those skilled in the art will appreciate that the accompanying drawings are provided for a better understanding of the present invention and do not constitute any limitation on the scope of the present invention.
[0042] Figure 1 This is a schematic diagram of the overall structure of a dense mesh support according to an embodiment of the present invention;
[0043] Figure 2 is a cross-sectional schematic diagram of a dense mesh support according to an embodiment of the present invention;
[0044] Figure 3 It is a partial enlarged view of the cross section of a dense mesh stent according to an embodiment of the present invention, wherein the wall thickness of the dense mesh stent is 1.0 times the wire diameter;
[0045] Figure 4 is a schematic cross-sectional view of a dense mesh support according to an embodiment of the present invention;
[0046] Figure 5 It is a schematic cross-sectional view of a dense mesh stent in accordance with an embodiment of the present invention, in which the wall thickness is 0.5 times the wire diameter;
[0047] Figure 6 is a schematic cross-sectional view of a first embodiment of the present invention when the inner wall of a hollow tubular stent is processed;
[0048] Figure 7 is a schematic cross-sectional view of a dense mesh support having a smooth inner wall according to an embodiment of the present invention;
[0049] Figure 8is a schematic structural diagram of a dense mesh support coated with developer at the intersection of the second embodiment of the present invention;
[0050] Fig. 9 This is a schematic diagram of a dense mesh stent structure formed by mixing two developable metal wires and other degradable wires in a third embodiment of the present invention;
[0051] Fig.10 This is a schematic diagram of a dense mesh stent structure formed by mixing four developable metal wires and other degradable wires in a third embodiment of the present invention;
[0052] Fig.11 is a schematic structural diagram of a fourth embodiment of the present invention in which a developer is disposed on the surface of a hollow tubular support by spraying or dipping;
[0053] Fig.12 It is a schematic structural diagram of a dense mesh support woven by a spindle-type braiding machine according to an embodiment of the present invention. DETAILED DESCRIPTION
[0054] In order to make the purpose, advantages and features of the present invention clearer, the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the drawings are all in a very simplified form and are not drawn to scale, and are only used to conveniently and clearly assist in explaining the purpose of the embodiments of the present invention. In addition, the structure shown in the drawings is often a part of the actual structure. In particular, the emphasis of each drawing is different, and sometimes different scales are used.
[0055] As used in the present invention, the singular forms "a", "an" and "the" include plural objects, the term "or" is generally used in a sense including "and / or", the term "several" is generally used in a sense including "at least one", and the term "at least two" is generally used in a sense including "two or more". In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or suggesting relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or at least two of the features. The term "proximal end" is usually the end close to the operator, and the term "distal end" is usually the end close to the patient. "One end" and "the other end" as well as "proximal end" and "distal end" usually refer to two corresponding parts, which include not only the endpoints. The terms "installed", "connected" and "connected" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral one; it can be a mechanical connection or an electrical connection; it can be directly connected or indirectly connected through an intermediate medium, and it can be the internal connection of the two elements or the interaction relationship between the two elements. In addition, as used in the present invention, an element is arranged on another element, which usually only means that there is a connection, coupling, matching or transmission relationship between the two elements, and the connection, coupling, matching or transmission between the two elements can be direct or indirect through an intermediate element, and it cannot be understood as indicating or implying the spatial position relationship between the two elements, that is, one element can be in any position such as inside, outside, above, below or on one side of another element, unless the content clearly indicates otherwise. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0056] In the present application, "axial" refers to the direction along the longitudinal axis of the stent, "circumferential" refers to the direction around the longitudinal axis of the stent, and "radial" refers to the direction perpendicular to the longitudinal axis of the stent.
[0057] The purpose of the present invention is to provide a dense mesh stent and a preparation method thereof, aiming to provide a degradable stent suitable for FD treatment, which can eliminate or alleviate the space-occupying effect while realizing the blood flow guiding function of the metal stent, and also eliminate the long-term safety hazards of the stent in the body for a long time. In addition, the absorbable dense mesh stent provided by the present invention can also have the high mechanical properties of the metal stent, ensuring that the stent has a stable blood flow guiding function in the early stage of implantation. The present invention can also further reduce the wall thickness of the stent, and ensure that the stent has a smooth inner wall and good roundness, thereby better reducing the risk of thrombosis and effectively ensuring the smoothness of blood flow.
[0058] The present invention is described in detail below in conjunction with the accompanying drawings and preferred embodiments. In the absence of conflict, the following embodiments and features in the embodiments may complement or be combined with each other.
[0059] [Example 1]
[0060] Please refer to Figures 1 to 7 This embodiment provides a dense mesh stent 10 that can be degraded and absorbed. Fig.12 The present invention also provides a method for preparing a dense mesh stent, comprising the following steps:
[0061] Providing a plurality of threads 11, at least some of the threads 11 are degradable threads;
[0062] Weaving a plurality of wires 11 on a core shaft 21 to form a hollow tubular stent 10';
[0063] After the hollow tubular stent 10' is formed, the mandrel 21 is heated to perform heat treatment on the hollow tubular stent 10' on the mandrel 21;
[0064] After the heat treatment, the hollow tubular stent 10 ′ is cooled and then separated from the core shaft 21 , thereby obtaining the dense mesh stent 10 provided by the hollow tubular stent 10 ′.
[0065] The outer diameter of the mandrel 21 is the same as the inner diameter of the dense mesh stent 10 to be finally prepared. The mandrel 21 is usually a round rod, which can better control the roundness of the inner cavity of the stent.
[0066] Therefore, the dense mesh stent 10 is formed by cross-weaving of multiple wires 11, and the multiple wires 11 cross each other to form multiple intersections 12 and multiple meshes 13. The meshes 13 are usually rhombus-shaped, and the rhombus shape is relatively stable, which can improve the bearing capacity of the meshes 13 themselves.
[0067] In some embodiments, all the wires 11 are degradable wires, and all of them can be degraded and absorbed. In some embodiments, some of the wires 11 are degradable wires, and some of the wires 11 are developable metal wires. In other embodiments, all the wires 11 are degradable wires, and developable metal wires are wound around at least some of the degradable wires. Alternatively, all the wires 11 are degradable wires, and developer is coated on at least some of the wires 11. In this embodiment, all the wires 11 are degradable wires, that is, the dense mesh stent 10 is woven from degradable wires as a whole.
[0068] The degradable silk adopts various known biodegradable materials, which are not limited in the present application. Currently commonly used biodegradable materials include polylactic acid (PLA), L-polylactic acid (PLLA or LPLA), polyglycolic acid / polylactic acid copolymer (PGLA), polycaprolactone (PCL), poly-p-dioxanone (PPDO) and copolymers or blends of these materials, but are not limited thereto.
[0069] The dense mesh stent 10 has a high material coverage rate and high mesh density, and can be used for the treatment of intracranial aneurysms, namely FD treatment, so as to reshape the blood flow in the blood vessel at the neck of the parent artery, guide the blood flow impacting the aneurysm to the normal blood vessels at the distal end of the parent artery, reduce the impact of blood flow on the aneurysm, and restore the hemodynamics of the neck of the parent artery, thereby promoting thrombosis in the aneurysm cavity, and gradually shrinking the aneurysm cavity until it heals.
[0070] After being implanted in the body, the dense mesh stent 10 can provide a place for vascular endothelial cells to climb and grow, promote endothelialization of the neck of the aneurysm, and reduce the risk of aneurysm rupture and recurrence. In addition, because the dense mesh stent 10 is degradable, while achieving the basic function of metal FD blood flow guidance to eliminate or alleviate the intracranial space-occupying effect, the blood vessels are restored to their original state through the degradation and absorption of the degradable material, eliminating the long-term safety hazards of the stent, ultimately improving the treatment effect and reducing the treatment cost.
[0071] Since the degradable material is a polymer material, the mechanical properties of the polymer material are weaker than those of metal materials. In view of this problem, in the present invention, at least part of the wires 11 are fixed at the corresponding intersection 12, that is, the wires 11 and 11 are fixed at the intersection 12 to prevent the wires 11 from spreading out, so as to improve the radial supporting force of the dense mesh stent 10. After at least part of the wires 11 are fixed at the intersection 12, the relative slippage of the axial direction when the stent is subjected to radial force is reduced. The smaller the axial slippage, the greater the radial supporting force. In this way, the radial supporting force and local compressive resistance of the dense mesh stent 10 can reach the level of metal stents, ensuring that the stent has a stable blood flow guidance function in the early stage of implantation. Preferably, all the wires 11 are fixed at the corresponding intersections 12 to make the radial supporting force of the dense mesh stent 10 better.
[0072] In addition, the advantage of the above preparation method is that during the weaving process, each wire 11 can be uniformly stressed and tightly fitted on the core shaft 21, and then by heating, each wire 11 can be uniformly shrunk toward the core shaft 21 and tightly fitted on the core shaft 21, ensuring the stability of the overall shape of the stent and the uniformity of the mechanical properties. In addition, weaving on the core shaft 21 is also suitable for weaving fine wires, which is convenient for weaving fine wires into a dense mesh stent 10 suitable for FD, so as to better control the stent wall thickness and reduce the risk of thrombosis. See also Figure 4 , directly weaving and heat setting on the core shaft 21 can better control the inner diameter of the stent, so that the inner cavity of the dense mesh stent 10 is almost a standard circle (with an inner diameter of D), so that the dense mesh stent 10 has a good roundness, reducing the probability of blood thrombosis caused by eddy currents in the stent. Of course, the dense mesh stent 10 can also shrink and expand, and has good elasticity and flexibility.
[0073] In practice, one way to fix the wire 11 at the intersection 12 is heat treatment, specifically, after weaving to form the hollow tubular bracket 10', the core shaft 21 is heated to a first temperature, the first temperature is higher than the glass transition temperature of the wire 11, and lower than the initial melting point of the wire 11 but not exceeding the initial melting point, so that the wire 11 is melted into one at the intersection 12 to form a fixed point without relative sliding.
[0074] In more detail, after the hollow tubular stent 10' is formed, the mandrel 21 is directly heated without removing the mandrel 21, so that the hollow tubular stent 10' on the mandrel 21 is heated, and then the wires 11 are melted into one at the intersection 12. After cooling, a dense mesh stent 10 with a stable shape and uniform mechanical properties can be obtained. Thus, the hollow tubular stent 10' is directly woven on the mandrel 21 and then heated, which can not only heat-set the hollow tubular stent 10', but also make at least part of the wires 11 melt into one at the intersection 12.
[0075] The first heating temperature is usually close to the initial melting point of the wire 11. The initial melting point at this time refers to the temperature when the material just begins to melt, and at this time, it can be seen that the solid material begins to collapse and has a wet phenomenon. If the first heating temperature reaches the initial melting point of the wire 11, the mechanical properties of the stent will decrease rapidly. Therefore, preferably, the absolute value of the difference between the first heating temperature and the initial melting point is 0 to 20°C.
[0076] Another way to fix the wire 11 at the intersection 12 is to perform a glue dispensing treatment. Specifically, after the heat-treated hollow tubular stent 10' is separated from the core shaft 21, a liquid containing medical glue is applied to the intersection 12 of the fixed wire 11. At this time, the temperature of the heated core shaft 21 can be the first temperature above, that is, after the heat treatment fixes the intersection 12, the glue is further dispensed to fix the intersection 12. Alternatively, during the glue dispensing treatment, the temperature of the heated core shaft 21 is the second temperature, which is the setting temperature, and the second temperature is lower than the first temperature. At the second temperature, after heat setting, the core shaft 21 and the hollow tubular stent 10' are separated, that is, the core shaft 21 is pulled out of the heat-set hollow tubular stent 10', and then glue is dispensed on the hollow tubular stent 10' separately, so that the wire 11 to be fixed is bonded as a whole at the intersection 12. The second temperature is higher than the glass transition temperature of the filament 11 and lower than the initial melting point of the filament 11. Usually, the second temperature is close to the glass transition temperature. Preferably, the absolute value of the difference between the second temperature and the glass transition temperature of the filament 11 is 0-50°C.
[0077] It should be understood that for FD treatment, thin wire weaving should be used as much as possible to better control the stent wall thickness and avoid thrombosis. Preferably, the wire diameter (d) of the wire 11 is 0.0010in to 0.0045in. However, from the current clinical application, there is a risk of thrombosis when the stent wall thickness reaches more than 120μm, and the wall thickness of the dense mesh stent 10 of the present invention can stably control the stent wall thickness below 120μm, and further control the stent wall thickness below 100um, which can effectively reduce the probability of thrombosis in the stent.
[0078] Preferably, the wall thickness of the dense mesh stent 10 (i.e., the hollow tubular stent 10' after heat treatment) is 0.5d-1.0d, where d is the diameter of the round wire (i.e., the wire diameter). For example, in this embodiment, when the wire diameter of the round wire 11 is 0.0010in-0.0045in, the maximum wall thickness of the stent is 114.3μm (corresponding to a wire diameter of 0.0045in).
[0079] However, if the traditional processing method is used, the wires 11 and 11 overlap at the intersection 12 to form a wire diameter of 2 times. The present invention can melt the wires 11 and 11 into one at the intersection 12 through heat treatment (first temperature), forming a wire diameter of 1 times at most, and further forming a wire diameter of 0.5 times. Therefore, the wall thickness of the stent is reduced, effectively reducing the risk of thrombosis. In this regard, after the core shaft 21 is heated to the first temperature, the first temperature can also slightly melt part of the material of the hollow tubular stent 10' that is close to the core shaft 21, so that the wall thickness of the hollow tubular stent 10' does not exceed the wire diameter (d) of the round wire.
[0080] Please refer to Figure 2 and Figure 3In one embodiment, a round wire 11 is used to weave a hollow tubular stent 10'. After weaving, the wires 11 and 11 are heat treated (first temperature) to melt into one at the intersection 12, that is, the wires 11 and 11 at the intersection 12 completely overlap, so that the wall thickness of the intersection 12 is d, and d is the wire diameter of the round wire.
[0081] See also Figure 5 In another embodiment, the wires 11 and 11 at the intersection 12 completely overlap, but the wall thickness of the intersection 12 is 0.5d. For example, the semicircular wires 11 are directly used to weave into a hollow tubular stent, with the arc surface of the wire 11 facing outward and the plane of the wire 11 facing inward. After weaving, after heat treatment (first temperature), the wires 11 and 11 are melted into one at the intersection 12, and finally form an inner circle. Alternatively, the circular wires 11 are continued to be used for weaving. After weaving, during heat treatment, part of the material of the hollow tubular stent 10' close to the core shaft 21 is slightly melted, thereby reducing the original 1 times the wire diameter to 0.5 times the wire diameter, and forming an inner circle.
[0082] The inner wall of the dense mesh stent 10 should also be as smooth as possible to further reduce the risk of thrombosis. Figure 6 After the hollow tubular stent 10' is woven, the inner wall of the stent can be made smooth or completely smooth by heat treatment (first temperature). Generally, bulges are easily formed on the inner wall of the intersection 12 after weaving. In this case, the bulges can be eliminated by heat treatment. Figure 7 After heat treatment, the inner wall of the dense mesh stent 10 tends to be smooth, or completely smooth, thereby further reducing the risk of thrombosis.
[0083] The present application does not limit the weaving method of the dense mesh stent 10. The commonly used weaving method is 1 on 1, or 1 on 2, or 2 on 2, so that every 4 wires 11 form a mesh 13. The wire 11 can be a single strand or multiple strands, which is not limited. The number of braided wire heads is generally 24, 32, 36, 48, 72, or 96 or other numbers of wire heads.
[0084] Please refer to Fig.12 , a spindle-type weaving machine can be used to achieve the weaving of the dense mesh bracket 10. Here, those skilled in the art can refer to the prior art to understand the structure and weaving principle of the spindle-type weaving machine. Specifically, this application will not describe it in detail. When preparing the dense mesh bracket 10 of the embodiment of the present invention, it can be woven with wire or woven without wire, and there is no specific limitation. During weaving, the core shaft 21 moves relative to the weaving disk 22, and the moving direction of the core shaft 21 is along the central axis direction of the weaving disk 22. At the same time, the multiple spindles 23 on the weaving disk 22 move with each other, over and over again, driving the multiple wires 11, so that the multiple wires 11 are cross-woven onto the surface of the core shaft 21 to form a hollow tubular bracket 10'.
[0085] The thread 11 used in the present invention is a polymer thread (degradable thread), or a mixture of a polymer thread and a metal thread (developable metal thread).
[0086] Since the elastic modulus of polymer wire is much lower than that of metal wire, in order to ensure uniform wire tension during weaving, Fig.12 As shown, the present invention further adds a tension control module 24. The tension control module 24 can accurately control the tension of all silk threads, so that during the weaving process, the weaving tension is uniform, and the force on each diamond mesh size in the obtained mesh tube is more uniform, which can well eliminate local stress. Then, during the subsequent heat treatment process, the shrinkage ratio of the silk thread is also the same, and finally a dense mesh bracket 10 with uniform and stable overall mechanical properties can be obtained. All silk threads or all spindles 23 can be synchronously controlled by the same tension control module 24 to ensure that each silk thread is uniformly stressed. Alternatively, there are multiple tension control modules 24, and each silk thread or each spindle 23 is controlled by a corresponding tension control module 24.
[0087] In this embodiment, the tension control module 24 may include a force sensor, a controller and a tension adjustment mechanism, and the controller is respectively connected to the force sensor and the tension adjustment mechanism in communication. The force sensor can directly or indirectly detect the wire tension during the weaving process, and the controller further determines whether to adjust the wire tension according to the wire tension detected by the force sensor. If adjusted, the controller sends a signal to the tension adjustment mechanism, and the tension adjustment mechanism adjusts the wire tension according to the received signal until the adjusted wire tension meets the requirements. In practice, the wire tension to be met can be set according to the elastic modulus of the wire. Preferably, during the weaving process, the wire tension (or understood as the weaving stress) is controlled to be 10Mpa~100Mpa, which basically covers the elastic modulus of the existing polymer wire and the developable metal wire, and meets the tension control requirements for these wires. It should be noted that the controller can analyze the data collected by the force sensor, and determine whether the current wire tension is within the normal range according to the set wire tension range. If not, the controller will issue a command to adjust. This adjustment method can achieve fast and accurate adjustment, improve production efficiency and weaving quality.
[0088] The controller in this application is an electronic device or computing device that can control various hardware by executing a program, such as a PLC controller, a single-chip microcomputer, a microprocessor, etc. Those skilled in the art can know how to choose a controller based on the disclosure of this application and the common knowledge in the field. The force sensor in this application can be any type of force sensor, including but not limited to a tension sensor. The tension adjustment mechanism generally includes electrical components and mechanical components. After the electrical components output power, they drive the mechanical components to relax or tighten the wire, thereby adjusting the wire tension. The electrical components are mainly motors. There can be many structures for adjusting the wire tension, such as setting a number of tensioning wheels, adjusting the rotation speed of the tensioning wheels, adjusting the wire tension, or other methods, which are not limited in this application.
[0089] Please refer to Figure 1 The braiding angle α of the dense mesh stent 10 is preferably 9° to 45°. This improves the radial support force and flexibility of the dense mesh stent 10. The braiding angle α is defined as the angle formed by the wire 11 and the radial direction perpendicular to the longitudinal axis C1 of the stent. The blank rate of the dense mesh stent 10 is preferably 60% to 90%, that is, the material coverage rate is 10% to 40%. This ensures a high material coverage rate and mesh density to form a dense mesh.
[0090] The degradation time of the dense mesh stent 10 should be consistent with the time of the aneurysm repair. Preferably, the time of the dense mesh stent 10 to complete degradation is 6 to 24 months, preferably 10 to 18 months. It is understandable that the time of complete degradation starts from implantation in the body.
[0091] Furthermore, the dense mesh stent 10 is preferably fully developable (i.e., the whole body is developable), i.e., it can be developed in both the axial and circumferential directions, so that the condition of the dense mesh stent 10 in the body can be better monitored. There are many ways to achieve full development of the dense mesh stent 10, and at least one development method is selected to perform. The following is an exemplary description.
[0092] [Example 2]
[0093] The difference between the second embodiment and the first embodiment is that at least part of the intersections 12 can be developed under X-rays, and preferably, all the intersections 12 can be developed, thereby achieving full development of the dense mesh stent 10.
[0094] Please refer to Figure 8 Different from the first embodiment, the developer is applied to at least part of the intersections 12 to form developable points 14, thereby achieving full development of the dense mesh stent 10. The developer can be applied to the intersections 12 of the hollow tubular stent 10' when the mandrel 21 is removed or not.
[0095] One method is to mix the developer and the medical glue, and then apply the liquid containing the developer and the medical glue to the intersection 12 by dispensing. Another method is to mix the developer and the organic solvent to form a developing solution, and then apply the developing solution to the intersection 12. Alternatively, the developer, the medical glue and the organic solvent are mixed and then applied to the intersection 12 together.
[0096] Commonly used developers include iohexol and small particle tantalum powder, but are not limited thereto. Commonly used organic solvents include acetone and ethylene glycol, but are not limited thereto.
[0097] [Example 3]
[0098] The difference between the third embodiment and the first embodiment is that among the multiple filaments 11, at least part of the filaments 11 can be visualized under X-rays.
[0099] like Fig. 9 and Fig.10 As shown, unlike the first embodiment, the dense mesh stent 10 provided in the third embodiment is made of a mixture of degradable wires 15 and developable metal wires 16. There is at least one developable metal wire 16, and at most four, preferably two or four. Preferably, the degradable wire 15 accounts for about 90%. The developable metal wire 16 plays a developing role, and multiple developable metal wires 16 can enhance the developing performance. The developable metal wire 16 extends spirally along the longitudinal axis C1 of the stent to achieve full development of the dense mesh stent 10.
[0100] like Fig. 9 As shown, there are two developable metal wires 16, and the two developable metal wires 16 are cross-woven with the degradable wire 15 in a double helix manner to form a dense mesh stent 10. The two developable metal wires 16 are arranged in reverse parallel.
[0101] like Fig.10 As shown, there are four developable metal wires 16 , two of which are arranged in parallel in the same direction, and the other two are arranged in parallel in the opposite direction, eventually forming two groups of double helices, so that the four developable metal wires 16 and the degradable wires 15 are cross-woven to form a dense mesh stent 10 .
[0102] However, the developable metal wire 16 may be eliminated, and the degradable wire 15 may be used entirely, and a developer may be coated on the surface of at least part of the degradable wire 15. Thus, before weaving, a developer is disposed on the degradable wire 15, and then weaving is performed. For example, the degradable wire 15 may be directly soaked in a developer solution for preparation. The developer is finally present on the degradable wire 15 in the form of a coating.
[0103] [Example 4]
[0104] The difference between the fourth embodiment and the first embodiment is that the developer is directly sprayed or dipped onto the entire dense mesh support 10 .
[0105] like Fig.11 As shown, after spraying or dipping the developer, the outer surface of the entire dense mesh stent 10 can be developed, that is, all the degradable silks 15 can be developed. The dense mesh stent 10 can be sprayed or immersed in the developer solution alone, and finally a developing coating is formed on the outer surface of the entire dense mesh stent 10, so that the dense mesh stent 10 can be fully developed.
[0106] In summary, according to the technical solution provided by the present invention, the dense mesh stent can bring many benefits while realizing the basic function of metal blood flow guidance to eliminate or alleviate the intracranial space-occupying effect. In addition to the effects mentioned above, it is also convenient to use non-invasive imaging technology without introducing image artifacts (i.e., without affecting the imaging) after the stent is degraded and absorbed, and after complete degradation and absorption, the patient avoids taking anti-thrombotic drugs for life, which not only reduces the toxic side effects brought to the patient, but also reduces the cost of treatment.
[0107] Therefore, the dense mesh stent 10 provided by the present invention can be used to treat intracranial aneurysms. After the aneurysm is completely occluded, the dense mesh stent 10 is gradually degraded and absorbed, which can eliminate the long-term rigidity of the artery in the stent implantation area. In the case of aneurysm recurrence, other treatment options can be selected, such as re-implanting stents or other devices to reduce the difficulty of later treatment. Compared with metal materials, degradable materials are more biologically active, can stimulate aneurysm neck endothelialization faster, and have better therapeutic effects.
[0108] The above description is only a description of the preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. Any changes or modifications made by a person skilled in the art in the field of the present invention based on the above disclosure shall fall within the scope of protection of the technical solution of the present invention.
Claims
1. A method for preparing a dense mesh stent, characterized in that: include: providing a plurality of filaments, at least some of which are degradable filaments; Weaving a plurality of the filaments on a core shaft to form a hollow tubular stent; After forming the hollow tubular stent, heating the mandrel to perform heat treatment on the hollow tubular stent on the mandrel; After the heat treatment, the hollow tubular support is cooled, and then the hollow tubular support and the mandrel are separated to obtain a dense mesh support provided by the hollow tubular support; Wherein, a plurality of the wires are crossed with each other to form a plurality of intersections and a plurality of meshes, and at least part of the wires are fixed at the corresponding intersections.
2. The method for preparing a dense mesh stent according to claim 1, characterized in that: The heating temperature of the mandrel is a first temperature, which is higher than the glass transition temperature of the filament and does not exceed the initial melting point of the filament.
3. The method for preparing a dense mesh stent according to claim 2, characterized in that: The absolute value of the difference between the first temperature and the initial melting point of the silk is 0-20°C.
4. The method for preparing a dense mesh stent according to claim 2 or 3, characterized in that: The first temperature is configured to satisfy at least one of the following conditions: Condition 1: causing at least part of the filaments to be melted into one at the corresponding intersections; Condition 2: slightly melting the part of the material of the hollow tubular stent close to the core shaft so that the wall thickness of the hollow tubular stent does not exceed the wire diameter of the round wire; Condition three: slightly melt the part of the material of the hollow tubular support close to the core shaft to make the inner wall of the hollow tubular support smooth.
5. The method for preparing a dense mesh stent according to claim 4, characterized in that: When the first temperature is configured to satisfy the second condition, the wall thickness of the hollow tubular support is 0.5 to 1.0 times the diameter of the circular wire.
6. The method for preparing a dense mesh stent according to claim 1, characterized in that: After the hollow tubular stent and the mandrel are separated, the method further comprises: A liquid containing medical glue is applied to the intersections where the wires are fixed.
7. The method for preparing a dense mesh stent according to claim 6, characterized in that: The liquid also includes a developer.
8. The method for preparing a dense mesh stent according to claim 1, characterized in that: The heating temperature of the mandrel is a second temperature, the second temperature is higher than the glass transition temperature of the filament, and the absolute value of the difference between the second temperature and the glass transition temperature is 0 to 50°C.
9. The method for preparing a dense mesh stent according to claim 1, characterized in that: The wire diameter of the wire is 0.0010in to 0.0045in.
10. The method for preparing a dense mesh stent according to claim 9, characterized in that: The wall thickness of the hollow tubular stent does not exceed 100 μm.
11. The method for preparing a dense mesh stent according to claim 1, characterized in that: The braiding angle of the hollow tubular support is 9° to 45°, and the blank rate of the hollow tubular support is 60% to 90%.
12. The method for preparing a dense mesh stent according to claim 1, characterized in that: Also includes: The hollow tubular stent can be fully developed through at least one development method.
13. The method for preparing a dense mesh stent according to claim 12, characterized in that: The hollow tubular stent can be fully developed by at least one of the following development methods, including: Development method 1: coating a developer on at least part of the intersections; Development method 2: all the silks are degradable silks, and a developer is coated on the surface of at least part of the degradable silks; Development method three: some of the wires are developable metal wires; Development method 4: spraying or dipping the developer on the hollow tubular support; Development method five: winding a developable metal wire around at least a portion of the wire.
14. The method for preparing a dense mesh stent according to claim 1, characterized in that: All of the wires are fixed at corresponding intersections.
15. The method for preparing a dense mesh stent according to claim 1, characterized in that: Also includes: During the weaving process, the thread tension is detected in real time. If the detected thread tension does not meet the requirements, the thread tension is adjusted.
16. A dense mesh support, characterized in that: The dense mesh stent is prepared by the preparation method of any one of claims 1 to 15.
Citation Information
Patent Citations
Vascular stenting for aneurysms
CN102573701A
Gastric fluid director and support thereof
CN107126306A
Textile-based enhanced degradable tube cavity support and preparation method and application thereof
CN107320224A
Degradable luminal stent with thermal adhesive composite structure, and preparation method thereof and application thereof
CN108066048A
Self-expanding biodegradable stent
US20090157158A1
Cited By
Locally degradable active dense net stent and preparation method thereof
CN120132076A
Double-layer hot-melt stent, manufacturing method and double-layer hot-melt stent release device
CN120643344A
